Phoenix Biotech Acquisition Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 0.667736 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3799 USD | +5.65% |
|
-43.57% | -96.55% |
1st Jan change | Capi. | |
---|---|---|
-96.55% | 5.72M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022